fidarestat has been researched along with Asthma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aguilera-Aguirre, L; Boldogh, I; Boulares, HA; Calhoun, WJ; Naura, AS; Ramana, KV; Srivastava, SK; Yadav, UC | 1 |
Aguilera-Aguirre, L; Boldogh, I; Ramana, KV; Srivastava, SK; Yadav, UC | 1 |
2 other study(ies) available for fidarestat and Asthma
Article | Year |
---|---|
Aldose reductase inhibition prevents allergic airway remodeling through PI3K/AKT/GSK3β pathway in mice.
Topics: Airway Remodeling; Aldehyde Reductase; Animals; Asthma; Biomarkers; Chronic Disease; Disease Models, Animal; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Hypersensitivity; Imidazolidines; Inflammation; Lung; Metaplasia; Mice; Mucus; Ovalbumin; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1 | 2013 |
Aldose reductase deficiency in mice protects from ragweed pollen extract (RWE)-induced allergic asthma.
Topics: Aldehyde Reductase; Ambrosia; Animals; Asthma; Imidazolidines; Mice; Mice, Knockout; Plant Extracts; Pollen; Rhinitis, Allergic, Seasonal; Treatment Outcome | 2011 |